JDD January 2021 Issue Highlights: From COVID-19 Vaccine to Facial Rejuvenation
The January issue of the Journal of Drugs in Dermatology focuses on Aesthetics Treatments, featuring an outstanding line-up of original articles from COVID-19 vaccine to facial rejuvenation. Straight from the JDD Editor’s desk, we share this month’s issue highlights:
Aesthetic Office Disaster Preparedness and Response Plan is a proactive approach for aesthetic treatment offices to manage a …
The January issue of the Journal of Drugs in Dermatology focuses on Aesthetics Treatments, featuring an outstanding line-up of original articles from COVID-19 vaccine to facial rejuvenation. Straight from the JDD Editor’s desk, we share this month’s issue highlights:
Aesthetic Office Disaster Preparedness and Response Plan is a proactive approach for aesthetic treatment offices to manage a … Continue reading "JDD January 2021 Issue Highlights: From COVID-19 Vaccine to Facial Rejuvenation"
The following is a summary of one of the many Q&A sessions held during the 2020 Skin of Color Virtual Update. During this particular session, questions were moderated by SOCU Co-Chair Dr. Andrew Alexis and answered by Drs. Ginette Okoye and Candrice Heath. The audience posed important questions and the faculty offered insightful answers regarding atopic dermatitis, hidradenitis suppurativa, h … 
To kick off the recent 2020 Integrative Dermatology Symposium, Drs. Peter Lio and Olivia Hsu Friedman, with the assistance of Ms. Kelly Barta, provided a fast-paced and comprehensive primer on how integrating conventional Western medicine with Traditional Chinese Medicine (TCM) and other Eastern approaches can serve to maximize outcomes for patients. Read on for some important takeaways to integra … 
Partnering Medical Therapies and Procedural Interventions to Treat the Whole Patient
Over the last decade, tremendous advances have revolutionized the treatment of chronic inflammatory skin conditions such as atopic dermatitis and psoriasis. These dermatological victories have shed light on skin diseases that need more attention. Hidradenitis suppurativa (HS), which disproportionately affects pat … 
When standard treatment options fail and corticosteroids are not a long-term option, dermatologists often have to look back to their tool-kit and pull out the “big guns.” Mycophenolate mofetil has emerged as a promising immunosuppressive agent for severe immune-mediated and inflammatory dermatologic disease. We continue our series, Therapeutic Cheat Sheet, with a closer look at mycophenolate m … 